Vitoc Vlad 4

What Happened Vitoc Vlad, CEO of MAIA Biotechnology, purchased 72,700 shares on 2026-06-01 in an open-market/private purchase (transaction code P). The filing reports a weighted-average price of $1.39 per share for a total cost of $100,886. This was a purchase (acquisition) rather than a sale.

Key Details

• Date: 2026-06-01 (reported on Form 4 filed 2026-06-02)
• Transaction type/code: Purchase (P), open market or private purchase
• Price: Weighted-average $1.39 per share; actual trade prices ranged $1.3634–$1.4150 (footnote F1)
• Total value: $100,886 (72,700 shares × $1.39 avg)
• Shares owned after transaction: Not specified in the provided filing
• Ownership note: These securities are beneficially owned by Mr. Vlad’s spouse; the reporting person disclaims beneficial ownership except for any pecuniary interest (footnote F2)
• Timeliness: Filing appears timely (transaction 2026-06-01, Form 4 filed 2026-06-02)

Context This was a direct purchase by the CEO (not an option exercise, award, gift, or 10b5-1 disclosure). Purchases by insiders can be viewed by investors as a stronger signal than sales, but the filing contains no explanation of intent. The weighted-average price and range indicate multiple trades; full per-trade details can be requested from the SEC staff or issuer as noted in the filing.